Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
BMC Cancer|April 21, 2025
Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancerManuel Valladares-Ayerbes, Marta Toledano-Fonseca, Begoña Graña, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2021
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trialFernando Rivera, Marta Izquierdo-Manuel, Pilar García-Alfonso, et al.
Frontiers in Immunology|December 21, 2016
KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid TumorsCristina Morales-Estevez, Juan De la Haba-Rodriguez, Barbara Manzanares-Martin, et al.
ESMO Open|December 6, 2019
Tumour location and efficacy of first-line EGFR inhibitors in <i>KRAS/RAS</i> wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trialsManuel Benavides, Eduardo Díaz-Rubio, Alfredo Carrato, et al.
NEJM Evidence|February 6, 2024
<i>Nab</i>-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic CancerAlfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla, et al.
Clinical Colorectal Cancer|March 17, 2012
Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive TumorsManuel Benavides, Carles Pericay, Manuel Valladares-Ayerbes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2021
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Manuel Benavides, Auxiliadora Gómez-España, Pilar García-Alfonso, et al.
European Journal of Clinical Investigation|August 1, 2025
Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patientsMarta Toledano-Fonseca, María Teresa Cano-Osuna, Elena Élez, et al.
Cancers|April 30, 2021
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular StudyElisa Conde, Julie Earl, Lorena Crespo-Toro, et al.
Pageof 15